Trial findings indicate that improved use of currently available medications lowers recurrence and increases cervical cancer survival.

Published Date: 25 Oct 2023

In order to determine whether a brief course of induction chemotherapy (IC) before chemoradiation (CRT) could lower the rate of relapse and death among patients with locally advanced cervical cancer, the INTERLACE phase III trial was conducted. As well.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

2.

Error on the MGUS-Autoimmune Disease Association.

3.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

4.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

5.

Unified Neuro/Psych Residency Program: New Proposal.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot